Thalidomide-O-C3-acid
Thalidomide-O-C3-acid Basic information
- Product Name:
- Thalidomide-O-C3-acid
- Synonyms:
-
- Butanoic acid, 4-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]-
- Thalidomide 4'-ether-alkylC3-acid
- Thalidomide-O-C3-acid
- CUN 66640
- 4-((2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxoisoindolin-4-yl)oxy)butanoic acid
- Thalidomide-4-O-C3-COOH
- 4-[[2-(2,6-Dioxopiperidin-3-yl)-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl]oxy)butanoic Acid
- 4-[[2-(2,6-Dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]butanoic acid
- CAS:
- 2169266-64-0
- MF:
- C17H16N2O7
- MW:
- 360.32
- Mol File:
- 2169266-64-0.mol
Thalidomide-O-C3-acid Chemical Properties
- Boiling point:
- 697.4±55.0 °C(Predicted)
- Density
- 1.502±0.06 g/cm3(Predicted)
- pka
- 4.56±0.10(Predicted)
Thalidomide-O-C3-acid Usage And Synthesis
Description
CUN 66640, also known as Thalidomide 4'-ether-alkylC3-acid is a cereblon ligand with alkyl linker and terminal acid for onward chemistry. This product has no formal name at the moment.
Uses
Thalidomide-O-C3-acid is a synthesized E3 ligase ligand-linker conjugate that incorporates the Thalidomide based cereblon ligand and a linker used in PROTAC technology[1].
IC 50
Cereblon
storage
Store at -20°C
References
[1] Sato T, et al. Cereblon-Based Small-Molecule Compounds to Control Neural Stem Cell Proliferation in Regenerative Medicine.?Front Cell Dev Biol. 2021;9:629326. Published 2021 Mar 11. DOI:10.3389/fcell.2021.629326
[2] Nalawansha DA, et al. PROTACs: An Emerging Therapeutic Modality in Precision Medicine. Cell Chem Biol. 2020;27(8):998-1008. DOI:10.1016/j.cell.2020.07.024
Thalidomide-O-C3-acidSupplier
- Tel
- 021-50460086-9 15921403865
- han_yajun@dctc.daicel.com
- Tel
- 021-61312847; 18021002903
- 3008007409@qq.com
- Tel
- +86-156-80926068 +86-15680926068
- 1924344760@qq.com
- Tel
- 13504435624
- 1927928688@qq.com
- Tel
- 025-86755008 17751752005
- hszhang@bestfluorodrug.com
Thalidomide-O-C3-acid(2169266-64-0)Related Product Information
- Thalidomide-4-O-C8-NH2
- Thalidomide-O-C5-acid
- Thalidomide-4-O-C6-NH2 hydrochloride
- Thalidomide-O-C6-acid
- Thalidomide-O-C10-NH2
- Thalidomide-O-C5-NH2
- Thalidomide-O-C6-NH2
- Thalidomide-linker 9
- Thalidomide-linker 6
- Thalidomide-O-C6-NH2 TFA
- Pentanoic acid, 5-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]-
- Propanoic acid, 3-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]-
- 1H-Isoindole-1,3(2H)-dione, 4-[(7-aminoheptyl)oxy]-2-(2,6-dioxo-3-piperidinyl)-
- Carbamic acid, N-[2-[2-[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]amino]ethoxy]ethoxy]ethyl]-, 1,1-dimethylethyl ester
- Propanoic acid, 3-[2-[2-[2-[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]ethoxy]ethoxy]ethoxy]ethoxy]-
- 4-[(4-Aminobutyl)amino]-2-(2,6-dioxopiperidin-3-yl)isoindoline-1,3-dione HCl
- 1H-Isoindole-1,3(2H)-dione, 5-(3-aminopropyl)-2-(2,6-dioxo-3-piperidinyl)-, hydrochloride (1:1)
- Propanoic acid, 3-[2-[2-[[2-(2,6-dioxo-3-piperidinyl)-2,3-dihydro-1,3-dioxo-1H-isoindol-4-yl]oxy]ethoxy]ethoxy]-, 2,5-dioxo-1-pyrrolidinyl ester